Enhanced imaging techniques for stroke diagnosis
Official title: Deep Enhanced Imaging in Stroke and Vascular Neurology
Run by Chinese PLA General Hospital · NCT05614193 · Data updated 2026-11-12
This study is testing whether new advanced imaging techniques can help doctors diagnose strokes faster and more accurately in patients who might have had a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 1, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 8, 2023 |
| Trial ID | NCT05614193 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are suspected of having experienced a stroke or cerebral ischemia and require brain imaging.
✕Probably not a fit
Patients with severe movement artifacts, a history of tumor lesions or craniocerebral surgery, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of deep learning-enhanced computed tomography (CT) and magnetic resonance (MR) imaging compared to conventional imaging methods in patients suspected of having a stroke or cerebral ischemia. The goal is to improve the speed and quality of imaging, which is crucial for timely treatment decisions in stroke care. By utilizing advanced deep learning techniques, the study aims to reduce the time patients spend in imaging sessions while enhancing the overall imaging quality. This could lead to better patient outcomes in vascular neurology.
Why it matters
Potential benefit: If successful, this approach could significantly improve the speed and accuracy of stroke diagnosis, leading to better patient care.
How similar studies have gone: While deep learning has shown promise in medical imaging, the specific application in stroke and vascular neurology is still being validated, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * suspecting to have experienced stroke or cerebral ischemia and needed to undergo brain imaging and vascular imaging including CT or MRI * no history of kidney failure * a minimum age of 18 years * obtained written informed consent Exclusion Criteria: * severe movement artifacts * incidental finding of tumor lesion or craniocerebral surgery history * poor imaging failed to perform deep learning method * women who pregnancy
Where it's running
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Jinhao Lyu
- Email: 330322990@qq.com
- Phone: +8615903562929
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
Cerebrovascular Reactivity Testing with HD-DOT in Sickle Cell Patients
This study tests whether high-density diffuse optical tomography can measure brain blood flow and oxygen use in people with sickle cell disease, to see how these signals relate to stroke risk.
-
Road-mapping versus ultrasound guidance for retrograde arterial puncture during angioplasty
This trial will test whether using road mapping or ultrasound to guide retrograde arterial puncture works better and is safer for adults with critical limb-threatening ischemia who need retrograde access during angioplasty.
-
Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD
This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.